Should You Add Beam Therapeutics Inc (BEAM) Stock to Your Portfolio Friday?

A rating of 94 puts Beam Therapeutics Inc (BEAM) near the top of the Healthcare sector according to InvestorsObserver. Beam Therapeutics Inc's score of 94 means that it ranks higher than 94% of stocks in the sector. In addition, its overall score of 68 ranks it higher than 68% of all stocks.

BEAM has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on BEAM!

See Full BEAM Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 68 would rank higher than 68 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Beam Therapeutics Inc Stock Today?

Beam Therapeutics Inc (BEAM) stock is down -1.56% while the S&P 500 is up 2.28% as of 12:39 PM on Friday, Jun 24. BEAM is down -$0.65 from the previous closing price of $41.57 on volume of 676,286 shares. Over the past year the S&P 500 has fallen -9.01% while BEAM is down -56.47%. BEAM lost -$3.61 per share the over the last 12 months. Click Here to get the full Stock Report for Beam Therapeutics Inc stock.